← Eichor
Study identifier: NCT01558479 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Parkinson's Genetic Research Study

Condition: Parkinson's Disease  ·  Sponsor: University of Washington

PhaseN/A
Planned participants5000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Pate  ·  1-855-646-4221

Khryss Capawa  ·  (206) 277-3956  ·  kcapawa@uw.edu

Always discuss trial participation with your own doctor first.

Locations (5)

Emory University/ Wesley Woods Health CenterAtlanta, Georgia, United StatesRecruiting
University of CincinnatiCincinnati, Ohio, United StatesRecruiting
Portland VA Medical CenterPortland, Oregon, United StatesRecruiting
VA Puget Sound Health Care SystemSeattle, Washington, United StatesRecruiting
University of WashingtonSeattle, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01558479